The hidradenitis suppurativa (HS) market is witnessing transformative progress, catalyzed by novel therapeutic developments, evolving epidemiological trends, and an increased focus on unmet clinical needs. Hidradenitis suppurativa is a chronic, inflammatory skin disorder characterized by painful, recurrent nodules and abscesses predominantly located in intertriginous regions. The condition...